DaVita (NYSE:DVA) Releases Earnings Results, Beats Expectations By $0.25 EPS

DaVita (NYSE:DVA) released its quarterly earnings results on Monday. The company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.25, Zacks reports. DaVita had a net margin of 7.31% and a return on equity of 115.48%. DaVita updated its FY 2025 guidance to 10.200-11.300 EPS.

DaVita Stock Performance

DVA traded up $0.53 during trading on Monday, reaching $144.29. 1,275,534 shares of the company’s stock were exchanged, compared to its average volume of 820,709. DaVita has a 1 year low of $131.44 and a 1 year high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a market capitalization of $11.09 billion, a P/E ratio of 13.43, a price-to-earnings-growth ratio of 1.07 and a beta of 1.14. The company’s fifty day simple moving average is $145.85 and its 200-day simple moving average is $153.83.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DVA. Barclays increased their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. StockNews.com raised shares of DaVita from a “hold” rating to a “buy” rating in a research report on Friday, April 25th. Finally, Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.